RLAY
Relay Therapeutics Inc
Price:  
3.60 
USD
Volume:  
1,034,389.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RLAY Fair Value

-370.09 %
Upside

What is the fair value of RLAY?

As of 2025-07-14, the Fair Value of Relay Therapeutics Inc (RLAY) is -9.72 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.60 USD, the upside of Relay Therapeutics Inc is -370.09%.

Is RLAY a good investment?

With the market price of 3.60 USD and our fair value calculation, Relay Therapeutics Inc (RLAY) is not a good investment. Investing in RLAY stocks now will result in a potential loss of 370.09%.

Note: valuation result may not be accurate due to the company's negative EPS.

3.60 USD
Stock Price
-9.72 USD
Fair Price
FAIR VALUE CALCULATION

RLAY Fair Value

Peter Lynch's formula is:

RLAY Fair Value
= Earnings Growth Rate x TTM EPS
RLAY Fair Value
= 5.00 x -1.94
RLAY Fair Value
= -9.72

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -52.41 -363.87 -290.51 -341.97 -337.71 -277.29
YoY growth 30.41% -594.28% 20.16% -17.71% 1.25% -112.03%

RLAY Fair Value - Key Data

Market Cap (mil) 617.18
P/E
Forward P/E
EPS -1.94
Avg earnings growth rate -112.03%
TTM earnings -333.39